Bonifacio, Rosalyn L.
HRN: 10-58-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CEFUROXIME 500MG (TAB)
09/15/2022
09/21/2022
ORAL
500
Bid
Msaf
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes